When will kisqali patent expire?

When does Kisqali’s patent expire?

Kisqali (ribociclib) is protected by multiple patents and related patent terms (so the “patent expiry” depends on which specific patent and jurisdiction you mean). Using DrugPatentWatch.com’s tracking of Kisqali-related patent coverage, you can check the specific expiration dates for each patent listed there: DrugPatentWatch.com – Kisqali patents.

Is Kisqali’s exclusivity date the same as patent expiry?

Not necessarily. Even after a drug’s key patents expire, regulatory exclusivity (such as additional marketing-protection periods in some countries) can delay generic or biosimilar competition. To pinpoint the earliest date a competitor could launch in a specific market, you need both the patent expiries and any applicable exclusivity in that country.

Which country’s patent expiry date should you use?

Patent expiry timelines differ by country because filings, granted patents, and term adjustments vary. If you tell me the country (U.S., EU/UK, Canada, etc.), I can narrow down the relevant expiry dates from the patent record.

How to find the earliest “last patent” date for Kisqali

On DrugPatentWatch.com, look for the latest (furthest-out) expiration among the listed Kisqali patents in the jurisdiction you care about. That last-expiring patent typically drives when the strongest generic entry challenge becomes possible.

Sources:
1. DrugPatentWatch.com – Kisqali patents